EDN1 and B-cell chronic lymphocytic leukemia: In conclusion, our findings demonstrate that macitentan impairs the pleiotropic actions of ET-1 signaling, concomitantly affecting multiple aberrant functions of CLL cells, i.e. survival, proliferation, angiogenesis, migration and chemoresistance.